Jacobs Bruce N. (CIK 0001821074)

Latest company ownership

Shares held
36,974
Last filed at
Sep 17, 2025
Confidence Score
42.8
2025Q4
Confidence Score History
2021Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 17, 2025 Sep 17, 2025 Kymera Therapeutics, Inc. CFO Sell 5.0 -79,220 -25.84% ✓ $4M
Mar 3, 2025 Mar 3, 2025 Kymera Therapeutics, Inc. CFO Sell 95.0 +22,965 12.84% ✗ $214.2K
Mar 1, 2024 Mar 4, 2024 Kymera Therapeutics, Inc. CFO Sell 95.0 +27,316 23.75% ✗ $164.7K
Mar 1, 2023 Mar 3, 2023 Kymera Therapeutics, Inc. CFO Sell 91.3 +22,380 27.23% ✓ $42.5K
Jan 12, 2022 Jan 14, 2022 Kymera Therapeutics, Inc. CFO Sell 7.5 -15,000 -46.13% ✓ $777.7K
Dec 3, 2021 Dec 3, 2021 Kymera Therapeutics, Inc. CFO Sell 7.5 -10,000 -36.35% ✓ $535.6K
Sep 3, 2021 Sep 3, 2021 Kymera Therapeutics, Inc. CFO Sell 7.5 -10,000 -57.95% ✓ $601.2K
Jun 3, 2021 Jun 4, 2021 Kymera Therapeutics, Inc. CFO Sell 7.5 -10,000 -34.78% ✓ $468.7K
Mar 11, 2021 Mar 15, 2021 Kymera Therapeutics, Inc. CFO Sell 7.5 -10,000 -100.00% ✓ $601.5K
Mar 8, 2021 Mar 8, 2021 Kymera Therapeutics, Inc. CFO Sell 7.5 -10,000 -100.00% ✓ $506.5K
Mar 3, 2021 Mar 5, 2021 Kymera Therapeutics, Inc. CFO Sell 7.5 -20,000 -100.00% ✓ $895.6K